Anteris Technologies, a structural heart company developing the world’s only balloon-expandable, 3D single-piece biomimetic aortic valve (DurAVR), has completed a A$35m (US$24m) equity fundraising. The company has issued 1.458 million…
Anteris Technologies, a structural heart company developing the world’s only balloon-expandable, 3D single-piece biomimetic aortic valve (DurAVR), has completed a A$35m (US$24m) equity fundraising. The company has issued 1.458 million…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference